Preclinical Overview of WHI-07, A Novel Nucleoside Analog-based Dual- Function Microbicide

Publisher： Bentham Science Publishers

E-ISSN： 1875-600x|3|1|15-29

ISSN： 1568-0126

Source： Current Medicinal Chemistry - Anti-Infective Agents, Vol.3, Iss.1, 2004-03, pp. : 15-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Search for a Topical Dual Action Spermicide/Microbicide

By  

Current Medicinal Chemistry, Vol. 14, Iss. 7, 2007-03 ,pp. : 775-786

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma

By Wong Chi   Loong Herbert   Hui Connie   Lau Cecilia   Hui Edwin   Ma Brigette   Chan Anthony  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1399-1408

Springer Publishing Company

Access to resources Recommend Favorite

Nucleoside Analog Inhibitors of Hepatitis C Virus Replication

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 17-29

Bentham Science Publishers

Access to resources Recommend Favorite

Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs

By Schönthal Axel H   Chen Thomas C   Hofman Florence M   Louie Stan G   Petasis Nicos A  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 197-208

Informa Healthcare

Access to resources Recommend Favorite

Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis

By Wu Bin   Li Te   Chen Huafeng   Shen Jinfang  

Value in Health, Vol. 13, Iss. 5, 2010-08 ,pp. : 592-600

Blackwell Publishing

Access to resources Recommend Favorite